Academic Staff

Assoc. Prof. Dr. Arthorn Riewpaiboon Assoc. Prof. Dr. Arthorn Riewpaiboon arthorn.rie@mahidol.ac.th arthorn.rie@mahidol.ac.th Department of Pharmacy, Faculty of Pharmacy, Mahidol University.

2021

1. Antibiotic use evaluation using WHO methodology in a private hospital, Yangon, Myanmar

   Maung H, Riewpaiboon A, Chanjaruporn *F. Pharmaceutical Sciences Asia 2021; 48(3): 269-276.
   
   

2. Cost analysis of influenza vaccination for pregnant women in Thailand

   Riewpaiboon A*. Pharmaceutical sciences asia 2021; 48(2) : 99-106.
   
   

3. Cost of premature mortality attributable to smoking in the Middle East and North Africa

   Nagi M, Riewpaiboon A, Thavorncharoensap M*. Eastern Mediterranean Health Journal 2021; 27(10): 974-983.
   
   

4. Cost-effectiveness analysis of diagnostic tests for para-aortic lymph node detection in locally advanced cervical cancer

   Katanyoo K, Chaikledkaew U*, Thavorncharoensap M, Riewpaiboon A. Clinicoecon Outcomes Res 2021; 13: 943-955.
   
   

5. Economic analysis for national immunization program planning: A case of rotavirus vaccines in Burundi

   Niyibitegeka F, Riewpaiboon A*, Youngkong S, Thavorncharoensap M. Vaccine 2021; 39(8) :1272-1282.
   
   

6. Economic burden of childhood diarrhea in Burundi

   Niyibitegeka F, Riewpaiboon A*, Youngkong S, Thavorncharoensap M. Global Health Research and Policy 2021; 6(1): 13.
   
   

7. Economic evaluation of rotavirus vaccination: an important step of the introduction to the national immunization program in Thailand

   Rochanathimoke O, Riewpaiboon A, Praditsitthikorn N, Tharmaphornpilas P, Jiamsiri S, Thavorncharoensap M, Postma MJ. Expert Review of Pharmacoeconomics and Outcomes Research 2021; 21(4): 811-819.
   
   

8. Health seeking behavior and experiences related to HIV treatment of people living with HIV (PLHIV) in Yangon, Myanmar

   Aung HNY, Riewpaiboon A, Sunantiwat M, Hone S, Thavorncharoensap M*. Pharmaceutical Sciences Asia 2021; 48(4): 320-329.
   
   

9. The Cost of locally advanced cervical cancer in Thailand: An empirical study for economic analysis

   Katanyoo K, Riewpaiboon A*, Chaikledkaew U, Thavorncharoensap M. Asian Pacific Journal of Cancer Prevention 2021; 22(10): 3171-3179.
   
   

10. Unit cost analysis of medical service in asia: A systematic review

    Dianingati RS, Riewpaiboon A*. Pharmaceutical sciences asia 2021; 48(2) : 185-193.
    
    

2020

1. Assessing the outcomes of farmers on promoting herbal medicine use

   Kwankhao P, Indaratna K, Anuratpanich L, Riewpaiboon A*. Pharmaceutical sciences asia 2020; 47(1): 43-50.
   
   

2019

1. Annual relative increased in inpatient mortality from antimicrobial resistant nosocomial infections in Thailand

   Phodha T, Riewpaiboon A, Malathum K, Coyte PC. Epidemiology and infection 2019; 147: e133.
   
   

2. Cost analysis in health promotion, disease prevention and controlling program in Asia: A systematic review

   Riewpaiboon A*, Dianingati RS. Pharmaceutical Sciences Asia 2019; 46(3); 163-174.
   
   

3. Cost analysis of pilot school-based HPV vaccination program in two provinces of Lao PDR

   Riewpaiboon A*, Pathammavong C, Fox K, Hutubessy R. Pharmaceutical Sciences Asia 2019; 46(1): 46-53.
   
   

4. Economic burden of rotavirus diarrhea in Thailand: Report from a pilot study on rotavirus vaccination

   Rochanathimoke O, Riewpaiboon A*, Tharmaphornpilas P, Jiamsiri S, Thavorncharoensap M, Postma MJ. Vaccine 2019; 37(4): 587-594.
   
   

5. Excess annual economic burdens from nosocomial infections caused by multi-drug resistant bacteria in Thailand

   Phodha T, Riewpaiboon A*, Malathum K, Coyte PC. Expert Review of Pharmacoeconomics and Outcomes Research 2019;19(3):305-312
   
   

6. Treatment cost and costing model of obstetric complications at a hospital in Myanmar

   Thi Win Shwe A, Riewpaiboon A*, Chaikledkaew U, Youngkong S. PLoS ONE 2019;14(3):e0213141
   
   

2018

1. A comparison of EQ-5D-3L index scores using Malaysian, Singaporean, Thai, and UK value sets in Indonesian cervical cancer patients

   Endarti D*, Riewpaiboon A, Thavorncharoensap M, Praditsitthikorn N, Hutubessy R, Kristina SA. Value in Health Regional Issues 2018; 15: 50-55.
   
   

2. Development of Relative Value Units for Unit Cost analysis of Medical Services in Vietnam

   Vo T.Q., Chaikledkaew U., Van Hoang M., Nguyen H.T., Riewpaiboon A. Asian Journal of Pharmaceutics 2018; 12(1): s19-s26
   
   

3. Estimating the economic impact of canine rabies to Viet Nam 2005-2014

   Shwiff S.A., Brown V.R., Dao T.T., Elser J., Trung H.X., Tien N.N., Huong N.T., Huong N.T.T., Riewpaiboon A., Ernst K., Shwiff S., Payne D. PLoS neglected tropical diseases 2018; 12(10): e0006866
   
   

4. Excess annual economic burdens from nosocomial infections caused by multi-drug resistant bacteria in Thailand

   Phodha T., Riewpaiboon A*., Malathum K., Coyte P.C. Expert Review of Pharmacoeconomics and Outcomes Research 2018; (Article in Press)
   
   

5. Health related quality of life impact from rotavirus diarrhea on children and their family caregivers in Thailand

   Rochanathimoke O, Riewpaiboon A, Postma MJ, Thinyounyong W, Thavorncharoensap M.* Expert Review of Pharmacoeconomics and Outcomes Research 2018; 18(2): 215-222
   
   

6. Health utilities of patients with multiple sclerosis and neuromyelitis optica spectrum disorders in Thailand

   Siritho S., Thavorncharoensap M., Chanatittarat C., Pasogpakdee P., Apiwattanakul M., Prayoonwiwat N., Chankrachang S., Riewpaiboon A., Chaikledkaew U. Multiple Sclerosis and Related Disorders 2018; 24: 151-156.
   
   

7. Hospital cost analysis in developing countries: A methodological comparison in Vietnam

   Vo T.Q., Chaikledkaew U., Van Hoang M., Nguyen H.T., Riewpaiboon A. Asian Journal of Pharmaceutics 2018; 12(1): S8-S18.
   
   

8. Knowledge, attitude, practice (KAP) and health related quality of life of priests with type 2 diabetes mellitus in Thailand

   Rajbhandari S, Riewpaiboon A, Peradhammanon P, Rattanaphanit S, Chanjaruporn F.* Pharmaceutical Sciences Asia 2018; 45(2): 93-104
   
   

9. Modelling the health economic impact of influenza vaccination strategies for high-risk children in Vietnam

   Vo T.Q., Chaikledkaew U., Van Hoang M., Riewpaiboon A. Journal of Clinical and Diagnostic Research 2018; 12(6): LC26-LC32.
   
   

10. National reference unit cost of health-care services: International experiences

    Vo T.Q., Van Hoang M., Riewpaiboon A. Asian Journal of Pharmaceutics 2018; 12(1): s27-s37
    
    

2017

1. Cost of Acute Care For Ischemic Stroke in Thailand

   Sribundit N*, Riewpaiboon A, Chaikledkaew U, Stewart JF, Tantirittisak T, Hanchaipiboolkul S. Southeast Asian Journal of Tropical Medicine and Public Health 2017; 48(3): 628-640.
   
   

2. Cost of pneumonia in children: A systematic review

   Sirisuksan V, Trung QV, Riewpaiboon A*. Pharmaceutical Sciences Asia 2017; 44 (1): 40-49
   
   

3. Economic burden of influenza at a tertiary hospital in Vietnam

   Vo TQ, Chaikledkaew U, Hoang MV, Riewpaiboon A.* Asian Pacific Journal of Tropical Disease 2017; 7(3): 144-150
   
   

4. Evaluating the first introduction of rotavirus vaccine in Thailand: Moving from evidence to policy

   Tharmaphornpilas P*, Jiamsiri S, Boonchaiya S, Rochanathimoke O, Thinyounyong W, Tuntiwitayapun S, Guntapong R, Riewpaiboon A, Rasdjarmrearnsook A-O, Glass RI. Vaccine 2017; 35(5): 796-801
   
   

5. Health seeking behavior and its determinants in Jaffna Sri Lanka

   Kalki P, Thavorncharoensap M, Riewpaiboon A*. Pharmaceutical Sciences Asia 2017; 44(3): 134-141
   
   

6. Social and economic burden of patients with influenza-like illness and clinically diagnosed flu treated at various health facilities in Vietnam

   Quang Vo T, Chaikledkaew U, van Hoang M, Riewpaiboon A*. ClinicoEconomics and Outcomes Research 2017; 9: 423-432
   
   

7. The health-economic studies of HPV vaccination in Southeast Asian countries: a systematic review

   Setiawan D*, Oktora MP, Hutubessy R, Riewpaiboon A, Postma MJ. Expert Review of Vaccines 2017; 16(9): 933-943.
   
   

2016

1. Cost of rotavirus diarrhea for programmatic evaluation of vaccination in Vietnam

   Riewpaiboon A*, Shin S, Le TP, Vu DT, Nguyen TH, Alexander N, Dang DA. BMC Public Health 2016; 16(1).
   
   

2. Effect of costing methods on unit cost of hospital medical services; A case of capital cost

   Riewpaiboon A*, Rajbhandari S, Coyte PC. Mahidol University Journal of Pharmaceutical Sciences 2016; 43 (2): 97-105
   
   

3. Evaluating the first introduction of rotavirus vaccine in Thailand: Moving from evidence to policy

   Tharmaphornpilas P., Jiamsiri S., Boonchaiya S., Rochanathimoke O., Thinyounyong W., Tuntiwitayapun S., Guntapong R., Riewpaiboon A., Rasdjarmrearnsook A.-O., Glass R.I. Vaccine 2016; 35(5): 796-801.
   
   

4. Healthcare costing studies in developing countries: A systematic review in Vietnam

   Vo TQ, Chaikledkaew U, Van Hoang M, Riewpaiboon A*. International Journal of Pharmaceutical Sciences Review and Research 2016; 39(2): 295-299.
   
   

5. Knowledge of Adverse Drug Reaction Reporting Among Healthcare Professionals in Bhutan: A Cross-Sectional Survey

   Dorji C, Tragulpiankit P*, Riewpaiboon A, Tobgay T. Drug Safety 2016; 39(12): 1239-1250.
   
   

6. Setting priorities for introducing new vaccines into the national immunization program; a systematic review

   Pooripussarakul S, Riewpaiboon A*. Mahidol University Journal of Pharmaceutical Sciences 2016; 43 (3): 135-142.
   
   

7. What criteria do decision makers in Thailand use to set priorities for vaccine introduction?

   Pooripussarakul S, Riewpaiboon A*, Bishai D, Muangchana C, Tantivess S. BMC Public Health 2016; 16(1): 684.
   
   

2015

1. Evaluation of Health-Related Quality of Life among Patients with Cervical Cancer in Indonesia

   Endarti D*, Riewpaiboon A, Thavorncharoensap M, Praditsitthikorn N, Hutubessy R, Kristina SA. Asian Pacific of Journal Cancer Prevention 2015; 16(8): 3345-3350
   
   

2. Knowledge About Adverse Drug Reaction and Reporting Among the Healthcare Professionals in Bhutan

   Dorji C, Tragulpiankit P, Riewpaiboon A, Tobgay T. Drug Safety 2015; 38(10): 946-946
   
   

3. Optimizing national immunization program supply chain management in Thailand: An economic analysis

   Riewpaiboon A*, Sooksriwong C, Chaiyakunapruk N, Tharmaphornpilas P, Techathawat S, Rookkapan K, Rasdjarmrearnsook A, Suraratdecha C. Public Health 2015; 129(7): 899-906
   
   

2014

1. Burden of care for persons with disabilities in Vietnam

   Riewpaiboon A*, Van Minh H, Huong NT, Dung P, Wright EP. Health and Social Care in the Community 2014; 22(6): 660-671
   
   

2. Cost of illness due to typhoid fever in Pemba, Zanzibar, East Africa

   Riewpaiboon A*, Piatti M, Ley B, Deen J, Thriemer K, von Seidlein L, SalehJiddawi M, Busch CJ-L, Schmied WH, Ali SM, Pak G, Ochiai LR, Puri MK, Chang NY, Wierzba TF, Clemens JD. Journal of Health, Population and Nutrition 2014; 32(3): 377-385
   
   

3. Health-Related Quauity of life in Patients with Cervical Cancer in Indonesia

   Endarti D*, Riewpaiboon A, Thavorncharoensap M. Value in Health 2014; 17(7): 738-739
   
   

4. Measurement of costs for health economic evaluation.

   Riewpaiboon A. J Med Assoc Thai. 2014; 97(5) :S17-26.
   
   

5. Quality of Life of Diarrheal Children and Caregivers in Thailand

   Rochanathimoke O*, Postma M, Thavorncharoensap M, Riewpaiboon A, Thinyounyong W. Value in Health 2014; 17(7): 368-369
   
   

6. Standard cost lists for health economic evaluation in Thailand.

   Riewpaiboon A. J Med Assoc Thai. 2014; 97(5) :S127-34.
   
   

2013

1. Economic evaluations of hepatitis A vaccination in middle-income countries

   Suwantika AA, Yegenoglu S, Riewpaiboon A, Tu H-AT, Postma MJ*. Expert Review of Vaccines 2013; 12(12): 1479-1494
   
   

2. Management of childhood asthma and role of pharmacist.

   Pooripussarakul S, Riewpaiboon A*. Mahidol University Journal of Pharmaceutical Sciences 2013; 40(1): 18-27.
   
   

3. สวัสดิการสังคมและการดูแลสุขภาพอย่างไม่เป็นทางการ: กรณีศึกษาการใช้การประเมินค่าทางเศรษฐศาสตร์ในการกำหนดเงินค่าชดเชยในประเทศไทย

   วัชรา ริ้วไพบูลย์, กันยารัตน์ ปนสูงเนิน, ซัสมิทา แชทเทอร์จี, อาทร ริ้วไพบูลย์. วารสารวิจัยระบบสาธารณสุข 2013; 7(1) : 86-98
   
   

2012

1. Antimicrobial resistance(AMR) in Thailand: A systematic review.

   Phodha T*, Riewpaiboon A, coyte PC, Thamlikitkul V. Value in Health 2012; 15: A602-A681.
   
   

2. Economic analysis for evidence-based policy-making on a national immunization program: A case of rotavirus vaccine in Thailand

   Muangchana C, Riewpaiboon A*, Jiamsiri S, Thamapornpilas P, Warinsatian P. Vaccine 2012; 30(18): 2839-2847
   
   

3. Economic evaluation of vaccination in southeast asian countries: a systematic review.

   Endarti D*, Riewpaiboon A. Value in Health 2012; 15: A602-A681.
   
   

4. Standard cost list for economic evaluation in Thailand.

   Riewpaiboon A* Value in Health 2012; 15: A602-A681.
   
   

5. ผลกระทบต้านสุขภาพและเศรษฐศาสตร์จากการติดเชื้อดื้อยาต้านจุลชีพในประเทศไทย : การศึกษาเบื้องต้น

   ภาณุมาศ ภูมาศ, ตวงรัตน์ โพธะ, วิษณุ ธรรมลิขิตกุล, อาทร ริ้วไพบูลย์, ภูษิต ประคองสาย, สุพล ลิมวัฒนานนท์ วารสารวิจัยระบบสาธารณสุข 2012; 6(3): 352-360.
   
   

2011

1. Cost analysis for efficient management: Diabetes treatment at a public district hospital in Thailand

   Riewpaiboon A, Chatterjee S*, Piyauthakit P. International Journal of Pharmacy Practice 2011; 19(5): 342-349
   
   

2. Cost analysis for reimbursement-rate setting of hospital pharmaceutical services in Thailand

   Riewpaiboon A*, Kumluang S. International Journal of Pharmacy Practice 2011; 19(5): 333-341
   
   

3. Cost of diabetes and its complications in Thailand: A complete picture of economic burden

   Chatterjee S, Riewpaiboon A, Piyauthakit P, Riewpaiboon W, Boupaijit K, Panpuwong N, Archavanuntagul V. Health and Social Care in the Community 2011; 19(3): 289-298
   
   

4. Cost-effectiveness of parenteral artesunate for treating children with severe malaria in sub-saharan Africa [Rentabilité de l"artésunate parentéral administer" chez les enfants gravement atteints de paludisme en Afrique subsaharienne]

   Lubell Y*, Riewpaiboon A, Dondorp AM, Von Seidlein L, Mokuolu OA, Nansumba M, Gesase S, Kent A, Mtove G, Olaosebikan R, Ngum WP, Fanello CI, Hendriksen I, Day NP, Whitea NJ, Yeungk S. Bulletin of the World Health Organization 2011; 89(7): 504-512
   
   

5. Disability and cost for diabetic patients at a public district hospital in Thailand

   Riewpaiboon A, Chatterjee S*, Riewpaiboon W, Piyauthakit P. International Journal of Pharmacy Practice 2011; 19(2): 84-93.
   
   

6. Economic evaluation of policy options for prevention and control of cervical cancer in Thailand

   Praditsitthikorn N*, Teerawattananon Y, Tantivess S, Limwattananon S, Riewpaiboon A, Chichareon S, Ieumwananonthachai N, Tangcharoensathien V. PharmacoEconomics 2011; 29(9): 781-806
   
   

7. ต้นทุนผู้ป่วยรายบุคคลสำหรับกลุ่มวินิจฉัยโรคร่วมประเทศไทย: วิธีต้นทุนจุลภาค

   อรทัย เขียวเจริญ, ศุภสิทธิ์ พรรณารุโณทัย, ชัยโรจน์ ซึงสนธิพร, อาทร ริ้วไพบูลย์ วารสารวิชาการสาธารณสุข 2011; 20(4): 572-585.
   
   

2010

1. Budget impact of the thalassemia management under the national health security scheme in Thailand

   Riewpaiboon A*, Bunyadharokul S, Chaikledkaew U, Torcharus K. Mahidol J Pharm. Sci 2010; 37(1-2): 28-39.
   
   

2. Cost-effectiveness analysis of home rehabilitation programs for Thai stroke patients

   Sritipsukho P, Riewpaiboon A, Chaiyawat P, Kulkantrakorn K. J Med Assoc Thai 2010;93 Suppl 7:S262-70.
   
   

3. Economic burden of beta-thalassemia/Hb E and beta-thalassemia major in Thai children.

   Riewpaiboon A*, Nuchprayoon I, Torcharus K, Indaratna K, Thavorncharoensap M, Ubol BO. BMC Res Notes 2010; 3:29.
   
   

4. Factors affecting health-related quality of life in Thai children with thalassemia.

   Thavorncharoensap M*, Torcharus K, Nuchprayoon I, Riewpaiboon A, Indaratna K, Ubol BO. BMC Blood Disord 2010; 10: 1.
   
   

5. Treatment costs of pneumonia, meningitis, sepsis, and other diseases among hospitalized children in Viet Nam

   Dang DA, Riewpaiboon A*, Le HT, Kim SA, Nyambat B, Kilgore P. J Health Popul Nutr. 2010; 28(5): 436-442.
   
   

2009

1. Economic evaluations of hepatitis B vaccination for developing countries

   Tu H-AT, Woerdenbag HJ, Kane S, Riewpaiboon A, Van Hulst M, Postma MJ*. Expert Rev Vaccines 2009; 8(7): 907-920.
   
   

2. Economic valuation of informal care in Asia: A case study of care for disabled stroke survivors in Thailand

   Riewpaiboon A*, Riewpaiboon W, Ponsoongnern K, Van den Berg B. Soc Sci Med 2009; 69(4): 648-653.
   
   

3. How the blind cope with problems of medicine utilization: a study in Bangkok, Thailand

   Riewpaiboon A*. Pharmacoepidem Dr S 2009; 18(8): 708-12.
   
   

4. Potential cost-effectiveness of a rotavirus immunization program in rural China

   Wang X-Y*, Riewpaiboon A, Von Seidlein L, Chen X-B, Kilgore PE, Ma J-C, Qi S-X, Zhang Z-Y, Hao Z-Y, Chen J-C, Xu Z-Y. Clin Infect Dis 2009; 49(8): 1202-1210.
   
   

5. Treatment cost of typhoid fever at two hospitals in Kolkata, India.

   Sur D, Chatterjee S*, Riewpaiboon A, Manna B, Kanungo S, Bhattacharya SK. J Health Pop Nutr 2009; 27(6): 725-32.
   
   

2008

1. A cost function analysis of shigellosis in Thailand.

   Riewpaiboon A, Youngkong S, Sreshthaputra N, Stewart JF, Samosornsuk S, Chaicumpa W, von Seidlein L, Clemens JD Value Health 2008;11 (Suppl 1) Mar: S75-S83.
   
   

2. A drug cost model for injuries due to road traffic accidents

   Riewpaiboon A, Piyauthakit P, Srijariya W, Chaikledkaew U Pharmacy Practice. 2008; 6(1) Jan: 9-14.
   
   

3. Economic burden of road traffic injuries: A micro-costing approach

   Riewpaiboon A, Piyauthakit P, Chaikledkaew U Southeast Asia J Trop Med Public Health 2008; 39(6): 1139-1149.
   
   

4. Measurement of costs

   Riewpaiboon A J Med Assoc Thai 2008; 91 (Suppl.2): S28-S37
   
   

5. Predicting the treatment cost of bacterial diarrhoea at a regional hospital in Thailand

   Riewpaiboon A, Intraprakarn K, Phoungkatesunthorn S J Health Pop Nutr 2008; 26(4): 442-50
   
   

6. The cost-effectiveness of typhoid Vi vaccination programs: Calculations for four urban sites in four Asian countries.

   Cook J, Jeuland M, Whittington D, Poulos C, Clemens J, Riewpaiboon A Vaccine 2008;26:6305-16
   
   

2007

1. Diabetes cost model of a hospital in Thailand

   Riewpaiboon A*, Pornlertwadee P, Pongsawat K. Value Health 2007; 10(4) Jul:223-30.
   
   

2. Effect of costing methods on unit cost of hospital medical services

   Riewpaiboon A*, Malaroje S, Kongsawatt S. Tropical Medicine and International Health 2007; 12(4) Apr: 554-63
   
   

3. Informal care of disabled stroke survivors: a case study in Thailand.

   Riewpaiboon W, Riewpaiboon A, Ponsoongnern K, Bernard Van den Berg Bull Dept Med Serv. 2007; 32(4): 473-85
   
   

2006

1. Increasing herbal product consumption in Thailand

   Riewpaiboon A*. Pharmacoepidemiology and Drug Safety 2006; 15(9): 683-686
   
   

2005

1. Cost structure of hospital-based pharmaceutical services: a consideration of reimbursement

   Riewpaiboon A, Jaroenkitpan N, Wipaswacharayotin Y Mahidol J Pharm Sci 2005; 32 (3-4): 47-54
   
   

2. Increasing Herbal Product Consumption in Thailand

   Riewpaiboon A Pharmacoepidemiology and Drug Safety 2005; 15: 683-6
   
   

2004

1. Unit costs of medical services at Prasart Neurological Institute

   Youngkong S, Riewpaiboon A, Towanabut S, Riewpaiboon W Srinakharinwirot J Pharm Sci 2004; 9(1): 52-8
   
   

2002

1. Cost of cerebral infarction in societal perspective

   Youngkong S, Riewpaiboon A, Towanabut S, Riewpaiboon W. Srinakharinwirot J Pharm Sci 2002; 7(1): 95-105
   
   

2. การวิจัยสมุนไพรด้านเศรษฐศาสตร์ กรอบแนวคิดและสถานการณ์ในประเทศไทย

   อาทร ริ้วไพบูลย์ วารสารวิชาการสาธารณสุข 2545; 11(4): 545-61
   
   

2001

1. Practice of herbal counseling of community pharmacists in Thailand

   Riewpaiboon A, Janewitvichaikul N and Pongcharoensuk P Pharmacoepidemiology and Drug Safety 2001; 10 (supplement): S45
   
   

2. Quality Predictors of Traditional Drugs Produced in Thailand.

   Riewpaiboon A, Temsiririrkkul R, Chulasiri M Mahidol J Pharm Sci 2001; 28(1-4): 17-27
   
   

1999

1. A proposal for an incentive scheme for promoting rational antibiotic use

   Riewpaiboon A, Sunderiand VB, Tangcharoensathien V, Paamore PR Mahidol J Pharm Sci 1999; 25(2): 36-43
   
   

2. Antimicrobial use evaluation

   Riewpaiboon A and Sunderland VB Frontiers in Plant Science 1999; 26(1-4): 44-51
   
   

3. Cost-benefit analysis of an incentive scheme for promoting antibiotic prescribing

   Riewpaiboon A,Sunderland VB,Tangcharoensathien V,Passmore PR Pharmacoepidemiology and Drug Safety 1999; 8 (Suppl 2): S141-2
   
   

1998

1. Increasing appropriate antibiotic prescribing in a Thai regional hospital by an innovative incentive scheme

   Riewpaiboon A, Sunderland VB, Sirinavin S, Tangcharoensathien V, Kongpatanakul S, Passmore PR Pharmacoepidemiology and Drug Safety 1998; 7 (Suppl 2): S186-7
   
   

1994

1. Physical Quality Evaluation on Traditional Tablets Registered in Thailand

   Riewpaiboon A Mahidol J Pharm Sci 1994; 21(1): 22-31
   
   

1993

1. The Study on Using Medicinal Plants for Self-Treatment of Diabetes Mellitus Patients Attended at Community Hospitals in Nakhonpathom Province

   Riewpaiboon A, Chuakul W, Riewpaiboon A, et al. Bull Dept Med Serv 1993; 18: 232-8
   
   

2. การใช้สมุนไพรของผู้ป่วยเบาหวาน ที่มารับบริการที่โรงพยาบาลชุมชนในจังหวัดนครปฐม.

   อาทร ริ้วไพบูลย์, วัชรา ริ้วไพบูลย์, วงศ์สถิตย์ ฉั่วกุล, คนอื่นๆ. วารสารกรมการแพทย์ 2536; 18: 232-8
   
   

1988

1. Constituents of Paramichelia baillonii. Three new Germacranolides

   Ruangrungsi N, Riewpaiboon A, Lange GL, Decices CP J Nat Prod 1988; 51(1): 163-7
   
   

1987

1. Constituents of Paramichelia baillonii: A New Germacranolide Alkaloid

   Ruangrungsi N, Riewpaiboon A, Lange GL, Picha P, Decices CP J Nat Prod 1987; 50(8): 891-6
   
   

---

หมายเหตุ: ชื่อที่ใช้ในการทำวิจัยของ Assoc. Prof. Dr. Arthorn Riewpaiboon ได้แก่ อาทร ริ้วไพบูลย์ ; Riewpaiboon A ;